Sullivan KM, Farraye FA, Winthrop KL, Willer DO, et al. Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions. Vaccine 2022 Nov 29:S0264-410X(22)01329-9. doi: 10.1016/j.vaccine.2022.
PMID: 36460534